HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
Authors:
- Andre J. MarozsanAMAndre J. Marozsan
- John P. MooreJMJohn P. Moore
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Potent Antiviral Synergy between Monoclonal Antibody and Small-Molecule CCR5 Inhibitors of Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2006
- Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2005
- The CCR5 Receptor-Based Mechanism of Action of 873140, a Potent Allosteric Noncompetitive HIV Entry InhibitorMolecular Pharmacology, 2005
- Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 InhibitorJournal of Virology, 2004
- Decreasing Sensitivity to RANTES (Regulated on Activation, Normally T Cell–Expressed and –Secreted) Neutralization of CC Chemokine Receptor 5–Using, Non–Syncytium‐Inducing Virus Variants in the Course of Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 2003
- The Crown and Stem of the V3 Loop Play Distinct Roles in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Interactions with the CCR5 CoreceptorJournal of Virology, 2002
- Increased CCR5 Affinity and Reduced CCR5/CD4 Dependence of a Neurovirulent Primary Human Immunodeficiency Virus Type 1 IsolateJournal of Virology, 2002
- Mapping the Determinants of the CCR5 Amino-Terminal Sulfopeptide Interaction with Soluble Human Immunodeficiency Virus Type 1 gp120-CD4 ComplexesJournal of Virology, 2001
- Perspective: Research Highlights at the Aaron Diamond AIDS Research Center : The β-Chemokines, HIV Type 1 Second Receptors, and Exposed Uninfected PersonsAIDS Research and Human Retroviruses, 1996
- HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5Nature, 1996